LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...